Bausch Health Companies Stock Market Value
| BHC Stock | USD 7.95 0.02 0.25% |
| Symbol | Bausch |
Bausch Health Companies Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Earnings Share (0.48) | Revenue Per Share 25.794 | Quarterly Revenue Growth 0.122 | Return On Assets 0.0415 |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bausch Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bausch Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bausch Health.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Bausch Health on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Bausch Health Companies or generate 0.0% return on investment in Bausch Health over 30 days. Bausch Health is related to or competes with Viatris, Catalent, Tilray, Zoetis, Emergent Biosolutions, Neurocrine Biosciences, and Teva Pharma. Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceuti... More
Bausch Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bausch Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bausch Health Companies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.84 | |||
| Information Ratio | 0.1301 | |||
| Maximum Drawdown | 17.92 | |||
| Value At Risk | (2.57) | |||
| Potential Upside | 6.3 |
Bausch Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bausch Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bausch Health's standard deviation. In reality, there are many statistical measures that can use Bausch Health historical prices to predict the future Bausch Health's volatility.| Risk Adjusted Performance | 0.1395 | |||
| Jensen Alpha | 0.5363 | |||
| Total Risk Alpha | 0.0354 | |||
| Sortino Ratio | 0.221 | |||
| Treynor Ratio | (6.44) |
Bausch Health Companies Backtested Returns
Bausch Health appears to be somewhat reliable, given 3 months investment horizon. Bausch Health Companies secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16% return per unit of risk over the last 3 months. By analyzing Bausch Health's technical indicators, you can evaluate if the expected return of 0.52% is justified by implied risk. Please makes use of Bausch Health's Risk Adjusted Performance of 0.1395, mean deviation of 2.03, and Downside Deviation of 1.84 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bausch Health holds a performance score of 12. The firm shows a Beta (market volatility) of -0.0817, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bausch Health are expected to decrease at a much lower rate. During the bear market, Bausch Health is likely to outperform the market. Please check Bausch Health's sortino ratio, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance , to make a quick decision on whether Bausch Health's price patterns will revert.
Auto-correlation | -0.81 |
Excellent reverse predictability
Bausch Health Companies has excellent reverse predictability. Overlapping area represents the amount of predictability between Bausch Health time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bausch Health Companies price movement. The serial correlation of -0.81 indicates that around 81.0% of current Bausch Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.81 | |
| Spearman Rank Test | -0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 0.2 |
Bausch Health Companies lagged returns against current returns
Autocorrelation, which is Bausch Health stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bausch Health's stock expected returns. We can calculate the autocorrelation of Bausch Health returns to help us make a trade decision. For example, suppose you find that Bausch Health has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bausch Health regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bausch Health stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bausch Health stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bausch Health stock over time.
Current vs Lagged Prices |
| Timeline |
Bausch Health Lagged Returns
When evaluating Bausch Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bausch Health stock have on its future price. Bausch Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bausch Health autocorrelation shows the relationship between Bausch Health stock current value and its past values and can show if there is a momentum factor associated with investing in Bausch Health Companies.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:Check out Bausch Health Correlation, Bausch Health Volatility and Bausch Health Alpha and Beta module to complement your research on Bausch Health. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Bausch Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.